Search

Jae Park, MD, a hematologic oncologist and assistant attending physician at MSK, will present findings about the durability of CAR T cell therapy response in patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) at the American Association for Cancer Research (AACR) Annual Meeting. This research has been selected to be featured in the meeting’s press program.

… Monday, April 3, 2017 Jae Park, MD , a hematologic oncologist and assistant attending physician at Memorial Sloan Kettering Cancer Center (MSK), will present findings about the durability of CAR T cell therapy response in patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) at the American

MSK Kids researchers publish report of screening and testing for COVID-19 in pediatric cancer patients in New York City.

… Wednesday, May 13, 2020 Researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) found that children with cancer are not at a higher risk of being affected by COVID-19. This new research led by Andrew Kung, MD, PhD, Chair of MSK Kids and his colleagues was published today in JAMA Oncology

An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.

… Wednesday, June 16, 2021 The majority of cancers are caused by random genetic changes and environmental exposures — things like sunlight, tobacco smoke, and the human papillomavirus (HPV). But Memorial Sloan Kettering researchers have found that, at least among people with metastatic or recurrent disease

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Here are some of the most important developments.

… Wednesday, December 14, 2022 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Clinical trials reported results of cutting-edge treatments, including new types of immunotherapy , radiation therapy , and experimental targeted

Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson, MD, President and CEO of MSK. MSK’s Carol Brown, MD, Ross Levine, MD, and Robert Sidlow, MD, were also active participants in the discussion. For more information about the event or to request an interview with a MSK roundtable participant, please e-mail [email protected].

… Thursday, May 26, 2016 Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, January 4, 2024 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Omar Abdel-Wahab Received the William Dameshek Prize from the American Society of Hematology Omar Abdel-Wahab, MD , leukemia specialist, Chair of the Molecular Pharmacology at the 

Scientists are learning that — in a literal sense — metastasis is wound healing gone wrong.

… Monday, January 13, 2020 Summary Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to coopt natural wound-healing pathways. The findings provide a new way of looking at metastasis and its possible treatment

Read about an MSK pilot study that could help patients get better sleep in the hospital overnight.

… Thursday, August 15, 2024 The constant beeping of machines. The frequent middle-of-the-night interruptions for blood draws and blood pressure checks. These are some of Luke Weber’s most vivid memories of being a 9-year-old getting treated for a rare pediatric cancer at  MSK Kids . “It felt like they

Learn how polycystic ovary syndrome (PCOS) may be linked to increased risk of pancreatic cancer.

… Thursday, October 6, 2022 Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects 1 in 10 women of childbearing age. A study suggests PCOS may be associated with as much as double the risk of pancreatic cancer . Memorial Sloan Kettering Cancer Center (MSK) epidemiologist Mengmeng “Margaret

Learn from the MSK President/CEO and Chair of the Board of Trustees about some of the most important advances in cancer care and science at MSK in 2024.

… Friday, June 6, 2025 The year 2024 will be remembered for the bold and strategic course we set to fulfill our mission of ending cancer for life. The need to plan for the future is urgent, as the Centers for Disease Control and Prevention (CDC) predicts the number of people with cancer is expected to